Discover 491 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Nevada offers a wide array of research opportunities for both healthy participants looking to take part in paid studies, as well as for those with specific medical needs. Major research hubs in Las Vegas, Reno, and Henderson are recruiting volunteers, giving access to cutting-edge treatments and advanced healthcare.
Filter
1
Filter results
Results: 491
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Location: Boston MA, Durham NC, Chapel Hill NC, Miami FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07294170
Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for
Clostridoides Difficile Associated Disease
Location: West Roxbury MA, Mineola NY, Manhasset NY,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT07282665
Phase 3, Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for
Alzheimer Disease, Agitation
Location: Newton MA, Morehead City NC, Virginia Gardens FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06937229
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Springfield MA, Albany NY, West Chester PA,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New Haven CT, Lake Mary FL, Louisville KY, Denver CO,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06459973
Phase 1, Phase 2, Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Burlington MA, Towson MD, Washington D.C. DC,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase 3, Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07783802
Phase 2, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Boston MA, Hartford CT, New York NY, New Brunswick NJ,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase 3, Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07100080
Phase 2, Phase 3, Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Bangor ME, West Chester PA, Kingston, Miami FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase 3, Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for
Uncontrolled Hypertension
Location: Boston MA, Methuen MA, Waterbury CT, The Bronx NY,
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All
Age: 18 - 70+
Code: NCT07142356
Phase 2, Recruiting
A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects
for
Menopause, Healthy Female Participants
Location: Las Vegas NV
Sponsor: Corium Innovations, Inc.
Sex: Female
Age: 40 - 70+
Code: NCT07794150
Phase 1, Recruiting
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV